Practical strategies for navigating the capricious regulatory landscape and maximising the value of IP within Life Science

Intellectual Property is the life blood of any Life Science organisations, and the effective management, protection, and enforcement of IP’s is essential to achieve success in such a competitive market. Life Science IP is the only IP event designed for in-house IPR professionals with a focus on the key issues of the year, including the Doctrine of Equivalents, Second-Medical use claims and SPCs. Furthermore, the event will also provide attendees with commercial strategies for maximising the value of their existing IP portfolio and will simultaneously explore the viability reduced-costs methods of IP protection. 

Download agenda

Early Confirmed Speakers Include

Lord Neuberger

Law Lord
UK House of Lords

Aaron Smethurst

Director, Intellectual Property Policy
UCB

Dr. Matthias Zigann

Presiding Judge
Regional Court Munich I

Kevin Mooney

Chairman of the Rules and Procedure Committee
UPC

Dr. Judy Jarecki-Black

Head, Patent Prosecution and Patent Litigation, Animal Health
Boehringer Ingelheim Animal Health

Jane Lambert QC

Barrister
4-5 Gray's Inn Square

Martyn Fish

Partner
HGF Limited

Michelle Davies

Legal Director
HGF Limited

Professor Mark Engelman QC

Head of Intellectual Property, Barrister
Hardwicke Chambers

Dr Sven Bostyn Lic.Jur., LLM, PhD

Associate Professor of Biomedical Innovation Law
Law Center for Advanced studies in Biomedical Innovation Law

Dr Guido Pontremoli

Corporate IP Patent Director
Chiesi

Harriet Strimpel

Chief IP Counsel
New England Biolabs

Ehab Shakour

CTO & IP Director
InnoSphere

Stephane Hauduc

Discovery Chemistry and Intellectual Property Manager
Destiny Pharma

Susan Dunn

CEO
Harbour Litigation Fund

Rahela Penovski

CEO
Cognedt

Nikolaos Papageorgiadis

Senior Lecturer
University of Liverpool

Denis Bayada

Product Manager Orbit
Questel

Fabienne Persijn

Key Account Executive
Questel

Bin Zheng

Partner, Patent Attorney
Unitalen Attorneys At Law

Benefits of attending

20+

SPEAKERS

80+

PARTICIPANTS

75%

PRACTITIONER
ATTENDEES

15+

HOURS
DEDICATED NETWORKING

Key Highlights to be addressed:

Receive updates and insights directly from the lawmakers, including QC Barrister Mark Engelman.

Learn more about the efficacy of patenting anti-bodies, biosimilars and bio-equivalents and how local experts are managing this at a regional level

Receive updates on the implications of recently concluded case law, including the Actavis 'Skinny Labelling' case. Hear how expert law firms and life sciences businesses will be adapting their IP strategy accordingly.

Work with industry experts, specialist law firms, licensing businesses and in-house counsels to generate effective IP portfolio management, commercialisation and monetisation strategies.

Discuss the viability of alternative forms of IP protection, including trade-secrets, confidential information, trademarks and copyright.

What our past attendees had to say about our events

Sponsors & Exhibitors
Media Partners